13F reference period
Q2 2026
Security Snapshot
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA) Institutional Ownership
CUSIP: 462260100
13F Institutional Holders and Ownership History from Q2 2017 to Q3 2026
Institutions Reporting
291
Shares (Excl. Options)
286.57M
Full value: 286,568,432 · shares · 30 Jun 2026Price
$4.16
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- IOVA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 286,568,432
- Total 13F value
- $1,192,013,604
- Portfolio coverage rank
- 0%
- Share change
- +17,691,395
- Value change
- +$74,712,019
- Number of holders
- 291
- Shares outstanding
- 451,979,229
- SEC-reported price per share
- $14.56
- Insider filing price
- $14.56
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- IOVA - IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK is tracked under CUSIP 462260100.
- 291 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 284 to 291 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$943.76M
Full value: $943,755,612 · USD · 31 Mar 2026.$1.19B
Full value: $1,192,013,604 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 291 institutions filings for Q2 2026.
Security key
462260100
13F reference period
Q2 2026
13F holders
291
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
IOVA full holder history
IOVANCE BIOTHERAPEUTICS, INC. SEC filings
IOVANCE BIOTHERAPEUTICS, INC. company facts
IOVANCE BIOTHERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 462260100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
IOVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.5% | +18% | $138,805,002 | +$50,173,494 | 33,366,587 | +57% | BlackRock, Inc. | 30 Jun 2026 |
| STATE STREET CORP | 4.8% | -12% | $315,879,244 | -$40,524,338 | 21,695,003 | -11% | STATE STREET CORPORATION | 30 Sep 2026 |
| PERCEPTIVE ADVISORS LLC | 3.8% | -50% | $45,599,285 | -$33,120,382 | 12,808,788 | -42% | Perceptive Advisors LLC | 31 Mar 2025 |
As of 30 Jun 2026,
291
institutional investors reported holding
shares of
IOVANCE BIOTHERAPEUTICS, INC. - COMMON STOCK (IOVA).
This represents
63%
of the company’s total
outstanding shares.
286.57M
Full value: 286,568,432 · shares · 30 Jun 2026451.98M
Full value: 451,979,229 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
51%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.2% | 36,957,681 | +19% | 0% | $153,743,956 |
| MHR FUND MANAGEMENT LLC | 6.4% | 28,967,103 | 0% | 6.3% | $120,503,148 |
| STATE STREET CORP | 5.4% | 24,478,268 | +40% | 0% | $101,829,595 |
| TWO SIGMA INVESTMENTS, LP | 4.2% | 19,010,697 | +39% | 0.06% | $79,084,500 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 18,204,248 | +9.5% | 0% | $75,729,672 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.2% | 14,388,999 | +23% | 0% | $59,858,236 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 10,324,826 | +20% | 0% | $42,958,080 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 8,525,919 | -9.4% | 0.02% | $35,467,823 |
| DIMENSIONAL FUND ADVISORS LP | 1.4% | 6,460,449 | +144% | 0% | $26,877,382 |
| Palo Alto Investors LP | 1.2% | 5,296,209 | -17% | 3% | $22,032,229 |
| GOLDMAN SACHS GROUP INC | 1.1% | 5,096,334 | -42% | 0% | $21,200,749 |
| Nuveen, LLC | 1.1% | 4,997,112 | +36% | 0% | $20,787,985 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 4,993,584 | -41% | 0% | $20,773,309 |
| MORGAN STANLEY | 1.1% | 4,986,461 | -20% | 0% | $20,743,678 |
| JUPITER ASSET MANAGEMENT LTD | 1% | 4,535,080 | 0.09% | $18,865,933 | |
| JANE STREET GROUP, LLC | 0.97% | 4,393,853 | +5.3% | 0.01% | $18,278,428 |
| NORTHERN TRUST CORP | 0.92% | 4,154,200 | +44% | 0% | $17,281,471 |
| AQR CAPITAL MANAGEMENT LLC | 0.86% | 3,869,584 | +520% | 0.01% | $16,097,468 |
| WELLS FARGO & COMPANY/MN | 0.72% | 3,246,537 | +57% | 0% | $13,505,594 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.71% | 3,219,656 | +16% | 0% | $13,393,769 |
| HRT FINANCIAL LP | 0.69% | 3,097,787 | -11% | 0.02% | $12,886,000 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.59% | 2,656,740 | -11% | 0.01% | $11,052,038 |
| VANGUARD FIDUCIARY TRUST CO | 0.56% | 2,542,878 | +16% | 0% | $10,578,372 |
| JPMORGAN CHASE & CO | 0.54% | 2,431,616 | -2.8% | 0% | $10,237,104 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.53% | 2,415,456 | -24% | 0% | $10,050,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
38
Headline period
Q2 2026
Rows shown
1-25 of 38
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 67,839,420 | $1,003,720,889 | -$24,525,682 | $14.82 | 145 |
| 2026 Q2 | 286,568,432 | $1,192,013,604 | +$74,712,019 | $4.16 | 291 |
| 2026 Q1 | 269,108,105 | $943,755,612 | +$17,298,033 | $3.51 | 284 |
| 2025 Q4 | 261,538,206 | $713,892,286 | +$134,068,597 | $2.73 | 261 |
| 2025 Q3 | 213,023,331 | $462,262,436 | -$12,426,646 | $2.17 | 249 |
| 2025 Q2 | 220,039,758 | $378,480,610 | -$103,966,458 | $1.72 | 244 |
| 2025 Q1 | 239,455,648 | $797,796,916 | -$41,501,290 | $3.33 | 292 |
| 2024 Q4 | 241,507,506 | $1,786,983,312 | +$22,988,107 | $7.40 | 294 |
| 2024 Q3 | 235,201,336 | $2,210,596,727 | +$25,452,589 | $9.39 | 280 |
| 2024 Q2 | 232,474,427 | $1,864,558,933 | +$97,335,567 | $8.02 | 287 |
| 2024 Q1 | 217,101,064 | $3,216,301,753 | +$212,421,390 | $14.82 | 266 |
| 2023 Q4 | 207,297,037 | $1,685,397,432 | -$32,505,370 | $8.13 | 233 |
| 2023 Q3 | 213,137,480 | $969,776,344 | +$6,686,675 | $4.55 | 223 |
| 2023 Q2 | 203,959,385 | $1,435,734,710 | -$789,310 | $7.04 | 214 |
| 2023 Q1 | 205,425,383 | $1,254,751,936 | +$199,378,894 | $6.11 | 225 |
| 2022 Q4 | 173,249,347 | $1,106,975,435 | +$100,178,837 | $6.39 | 213 |
| 2022 Q3 | 154,414,415 | $1,478,691,442 | -$53,630,372 | $9.58 | 231 |
| 2022 Q2 | 156,417,705 | $1,726,071,008 | +$13,073,879 | $11.04 | 227 |
| 2022 Q1 | 155,843,237 | $2,593,671,140 | -$16,926,612 | $16.65 | 231 |
| 2021 Q4 | 155,850,778 | $2,963,320,040 | -$77,138,233 | $19.09 | 235 |
| 2021 Q3 | 157,966,360 | $3,882,977,675 | -$126,474,780 | $24.66 | 238 |
| 2021 Q2 | 162,111,422 | $4,215,394,735 | +$75,696,267 | $26.02 | 226 |
| 2021 Q1 | 156,513,608 | $4,954,837,773 | +$228,194,179 | $31.66 | 240 |
| 2020 Q4 | 148,752,147 | $6,902,468,525 | +$436,980,892 | $46.40 | 264 |
| 2020 Q3 | 139,955,271 | $4,606,819,956 | -$20,115,200 | $32.92 | 245 |